Studies indicate that the interaction between MPC1 and mitochondrial STAT3 (mito-STAT3) disrupts the distribution of STAT3, reduces the activity of cytoplasmic STAT3 (cyto-STAT3), and promotes the malignant progression of lung cancer, including invasion and metastasis. Here, STAT3 is linked to lung carcinoma.